2 recruiting, 1 active not recruiting, 1 not yet recruiting, 1 unknown. 2 Not applicable, 2 Phase 4, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Active not recruiting 1, Unknown 1 |
| Phase 4 | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Nonobstructive Hypertrophic Cardiomyopathy: new trials by email Literature Review of Nonobstructive Hypertrophic Cardiomyopathy trials Research Report on Nonobstructive Hypertrophic Cardiomyopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dapagliflozin in Patients With Non-Obstructive Hypertrophic Cardiomyopathy: A Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Dapagliflozin 10mg, Dapagliflozin Placebo - Nonobstructive Hypertrophic Cardiomyopathy | Phase 4 | Not yet recruiting | Yonsei University | 440 | 2027-01-02 | 2026-10-27 |
| Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTX-001 HTX-001 - Nonobstructive Hypertrophic Cardiomyopathy | Phase 1 | Recruiting | Haya Therapeutics, Inc. | 10 | 2026-10-01 | 2026-10-27 |
| ENavogliflozin DElivering Alleviation of Ventricular Diastolic Dysfunction in nonObstRuctive Hypertrophic CardioMyopathy enavogliflozin 0.3mg, enavogliflozin Placebo - Nonobstructive Hypertrophic Cardiomyopathy | Phase 4 | Recruiting | Yonsei University | 200 | 2024-10-15 | 2024-11-08 |
| Transapical Beating-Heart Septal Myectomy in Patients With Symptomatic Nonobstructive Hypertrophic Cardiomyopathy Transapical beating-heart septal myectomy - Nonobstructive Hypertrophic Cardiomyopathy | Not applicable | Unknown | Xiang Wei | 100 | 2023-07-01 | 2023-07-19 |
| Transapical Beating-Heart Septal Myectomy for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy Transapical beating-heart septal myectomy - Nonobstructive Hypertrophic Cardiomyopathy | Not applicable | Active not recruiting | Xiang Wei | 100 | 2022-11-15 | 2025-12-08 |
Cardiomyopathy, Hypertrophic (1) · Mitral Valve Insufficiency (1)
Cardiovascular Diseases (2) · Heart Diseases (2) · Heart Valve Diseases (2) · Aortic Stenosis, Subvalvular (1) · Aortic Valve Disease (1) · Aortic Valve Stenosis (1) · Cardiomyopathies (1)
Enavogliflozin (1) · dapagliflozin (1)
Xiang Wei (2) · Yonsei University (2) · Haya Therapeutics, Inc. (1)
China (2) · South Korea (1) · United States (1)
In-Cheol Kim, MD (1) · Jang-Won Son, MD (1) · Jiwon Seo, MD (1) · Xiang Wei, M.D. (1)